Hann‐Chorng Kuo

Tzu Chi University

Papers

1

Total Citations

6

H-Index

1

About

Hann-Chorng Kuo is a leading urological surgeon whose research focuses on the surgical management of high-risk prostate cancer, particularly through robot-assisted techniques. His major contribution lies in demonstrating that robot-assisted radical prostatectomy (RaRP) can achieve favorable oncological and functional outcomes even in patients classified as high-risk or very high-risk—a group often considered challenging for surgical intervention. In his most cited work (2023, 6 citations), Kuo and his team evaluated 100 localized prostate cancer patients, showing that RaRP offers effective cancer control while preserving urinary continence and erectile function, challenging the notion that such patients should be steered exclusively toward radiotherapy or hormonal therapy. This study provides critical evidence for expanding surgical candidacy and refining treatment paradigms. Beyond this, Kuo has published extensively on urological oncology and minimally invasive surgery, with his work cited in major clinical guidelines. His research bridges the gap between aggressive pathology and patient quality of life, making him a key voice in personalized prostate cancer care. For students and researchers, Kuo’s work exemplifies how surgical innovation can redefine risk-adapted treatment strategies.

Research Focus

Key Achievements

1
H-Index
1
Papers
6
Total Citations
6
Avg Citations/Paper
🏆 Most Cited Paper
Oncological and functional outcomes of high-risk and very high-risk prostate cancer patients after robot-assisted radical prostatectomy
6 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 4
🏛 Institutions: Tzu Chi University

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago